Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

AnaptysBio initiates first-in-human trial of ANB-019

April 7, 2017

RepliCel Life Sciences reports interim data from phase I study of RCS-01

April 5, 2017

Avillion and Merck KGaA sign codevelopment agreement for IL-17 A/F Nanobody in plaque psoriasis

March 30, 2017

Cara Therapeutics reports topline data from Part A of phase II/III trial of CR-845

March 29, 2017

FDA approves Dupixent for moderate to severe atopic dermatitis

March 29, 2017

Allergan and Paratek announce results from phase III trials of sarecycline in acne

March 29, 2017

Foamix reports phase III topline results for FMX-101 in moderate to severe acne

March 28, 2017

Amryt initiates phase III trial of AP-101 for epidermolysis bullosa

March 28, 2017

Phase II trial of XEN-801 for acne does not meet efficacy endpoints

March 28, 2017

EMA validates regulatory filing of tildrakizumab in Europe

March 27, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026